|
Basic Information |
|
post buying leads |
|
Suppliers |
| Name |
Sodium sulfadiazine |
EINECS | 208-919-0 |
| CAS No. | 547-32-0 | Density | 1.496g/cm3 |
| Solubility | Melting Point |
|
|
| Formula | C10H9N4NaO2S | Boiling Point | 512.6oC at 760 mmHg |
| Molecular Weight | 272.26 | Flash Point | 263.8oC |
| Transport Information | UN 3249 | Appearance | |
| Safety | 22-26-36/37-45 | Risk Codes | 22-36/37/38-42/43 |
| Molecular Structure |
|
Hazard Symbols |
 Xn
|
| Synonyms |
Benzenesulfonamide,4-amino-N-2-pyrimidinyl-, monosodium salt (9CI);Sodium, (N1-2-pyrimidinylsulfanilamido)-(7CI);Sulfadiazine, sodium deriv. (6CI);Sulfanilamide, N1-2-pyrimidinyl-,monosodium salt (8CI);2-Sulfanilamidopyrimidine sodium salt;Monosodium2-sulfanilamidopyrimidine;Sodium 2-sulfanilamidopyrimidine;Sodium sulfapyrimidine;Sulfadiazine sodium;Sulfapyrimidine sodium; |
This chemical is called Sulfadiazine Sodium, and its CAS registry number is 547-32-0. With the molecular formula of C10H9N4NaO2S, its classification codes are Antibacterial; Drug / Therapeutic Agent; Mutation data; Reproductive Effect. Additionally, it's used for cure sulfonamide, susceptible infections and it can also be used for T. gondii infection. However, it should be stored at 2-8°C.
Other characteristics of the Sulfadiazine Sodium can be summarised as followings: (1)#H bond acceptors: 6; (2)#H bond donors: 3; (3)#Freely Rotating Bonds: 2; (4)Polar Surface Area: 106.35 Å2.
When you are using this chemical, please be cautious about it as the following: This chemical is irritating to eyes, respiratory system and skin. It may cause sensitization by inhalation and skin contacting. You should wear suitable protective clothing if you use it. In case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 1747mg/kg (1747mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 81, Pg. 17, 1944. | |
| mouse | LD50 | intravenous | 540mg/kg (540mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 94, Pg. 338, 1953. | |
| mouse | LD50 | oral | 1700mg/kg (1700mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 94, Pg. 338, 1953. | |
| mouse | LD50 | subcutaneous | 1408mg/kg (1408mg/kg) | Acta Medica Scandinavica, Supplement. Vol |
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
